Frontlight ResearchEarly access
Trial site
CHU Poitiers - Hôpital la Milétrie
- 7running trials
- 5closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Multiple myeloma3 trials
- Gastric and oesophageal cancer2 trials
- Lung cancer2 trials
- Chronic lymphocytic leukaemia1 trial
- Colorectal cancer1 trial
- Diabetic eye disease1 trial
- Endometrial cancer1 trial
- Hodgkin lymphoma1 trial
- Macular degeneration1 trial
- Melanoma1 trial
- Ovarian cancer1 trial
- Prostate cancer1 trial
- Phase
- Phase 36 trials
- Phase 22 trials
- Phase 11 trial
- Phase 1/21 trial
- Status
- Recruiting4 trials
- Active, not recruiting3 trials
- Completed3 trials
- Terminated2 trials
- Lead sponsor
- Janssen Research & Development, LLC3 trials
- Daiichi Sankyo2 trials
- Pierre Fabre Medicament2 trials
- Genmab1 trial
- Hoffmann-La Roche1 trial
- and 3 more
Running trials
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products
Active, not recruiting
Adjuvant Encorafenib and Binimetinib in High-risk Stage II Melanoma With a BRAF Mutation.
Active, not recruiting
A Study of Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer2 recruiting
- Colorectal cancer1 recruiting
- Multiple myeloma1 recruiting
Closed trials
Completed
A Study in Patients With BRAF V600E-mutant Metastatic Non-small Cell Lung Cancer (OCTOPUS)
Terminated
Terminated
Completed
Completed
Site data: ClinicalTrials.govUpdated 12 Nov 2026